Recently, MSMO1 is considered as a novel and critical gene target in various solid cancers, including breast cancer 11, oligodendroglia cells 12, hypopharyngeal cancer 17, gastric cancer 18, uveal melanoma 19, liver cancer 20 and cervical squamous cell carcinoma 21. Here, MSMO1 is linked to hypopharynx cancer.